BioWorld MedTech: “Chromacode looks to battle tickborne pathogens with new assay”

BioWorld Medtech reporter Liz Hollis has published a feature article – the top in the December 11th issue – on ChromaCode’s first-to-the-market HDPCR product: Tick-Borne Pathogen Panel (RUO).

BioWorld Medtech is one of the top medical device industry trades, with a subscription audience of approx. 18,500, focused on providing insight and information such as new product developments, company news, regulatory activity, legislative actions, strategic alliances, sales and mergers and market updates.

Read the full article here.